Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Innovaderm announced a major rebranding to Indero. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields.
read more
Tuesday, November 28, 2023
Thermo Fisher Scientific Inc. and Flagship Pioneering have unveiled a strategic partnership aimed at the rapid development and commercial scaling of multiproduct platforms.
read more
Innovative Targeting Solutions announced a research agreement with Eli Lilly and Company.
read more
Tuesday, October 15, 2019
Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level
read more
Thursday, January 02, 2025
Innovent Biologics, Inc. announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate. IBI3009 has already obtained IND approvals in ...
read more
Monday, December 17, 2018
Incyte and Innovent Biologics announced that the companies have entered into an agreement for three clinical-stage product candidates: pemigatinib, itacitinib and parsaclisib.
read more
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to ...
read more
Inotiv, a research organization specializing in nonclinical and analytical drug discovery and development services, acquired genetic toxicology assets from MilliporeSigma’s BioReliance® portfolio, including standard operating procedures, stock ...
read more
Inotiv, Inc. announced that the company has completed the purchase of Orient BioResource Center, Inc. (“OBRC”), from Orient Bio, Inc., a preclinical contract research organization and animal model supplier based in Seongnam, South Korea. Orient ...
read more
Inotiv announced the acquisition of Plato BioPharma (PBI), a Colorado-based, in vivo pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary and hepatic therapeutic areas. Transaction consideration totaled $...
read more
Tuesday, December 03, 2019
Bioanalytical Systems, doing business as Inotiv, announced the closing of the previously announced agreement to purchase substantially all of the assets of Pre-Clinical Research Services (PCRS).
read more
Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, announced that the Company has completed the purchase of its previously leased St. Louis facility for approximately $...
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more
Bioanalytical Systems announced the most recent hiring related to the continued expansion of the Company’s pathology service offerings through ongoing investment and key hires.
read more
Inotiv announced an expanded capacity to conduct Good Laboratory Practices (“GLP”) studies for in vitro cytogenetics and bacterial mutation assays as components of the Standard Battery of genetic toxicology studies required for first-in-human ...
read more